{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:02:52Z","timestamp":1792918972702,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omtm.2024.101208","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T18:31:33Z","timestamp":1707244293000},"page":"101208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome"],"prefix":"10.1016","volume":"32","author":[{"given":"Melissa","family":"Pille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong Q.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomeen","family":"Haerynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-8212","authenticated-orcid":false,"given":"Brian R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101208_bib1","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","article-title":"Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2024.101208_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omtm.2024.101208_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott-Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2024.101208_bib4","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/eji.201646715","article-title":"Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity","volume":"47","author":"Rivers","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2024.101208_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.04.007","article-title":"The role of WASp in T\u00a0cells and B cells","volume":"341","author":"Sun","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omtm.2024.101208_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.674572","article-title":"Wiskott-Aldrich Syndrome Protein: Roles in Signal Transduction in T Cells","volume":"9","author":"Ngoenkam","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtm.2024.101208_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2010\/781523","article-title":"The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function","volume":"29","author":"Blundell","year":"2010","journal-title":"Dis. Markers"},{"key":"10.1016\/j.omtm.2024.101208_bib8","doi-asserted-by":"crossref","first-page":"15424","DOI":"10.1073\/pnas.0706881104","article-title":"Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T\u00a0cell development","volume":"104","author":"Cotta-de-Almeida","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101208_bib9","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2024.101208_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101208_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","article-title":"Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for Wiskott-Aldrich syndrome","volume":"28","author":"Magnani","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101208_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ymthe.2004.08.008","article-title":"Lentiviral vector-mediated gene transfer in T\u00a0cells from Wiskott-Aldrich syndrome patients leads to functional correction","volume":"10","author":"Dupr\u00e9","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101208_bib13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2024.101208_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V126.23.260.260","article-title":"Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome","volume":"126","author":"Chu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2024.101208_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.stemcr.2016.06.003","article-title":"Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects","volume":"7","author":"Laskowski","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2024.101208_bib16","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A Web-based Tool for Identifying and Validating CRISPR\/Cas Off-target Sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2024.101208_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13059-019-1625-3","article-title":"iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity","volume":"20","author":"Nobles","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtm.2024.101208_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101208_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101208_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3408","article-title":"Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101208_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2024.101208_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41592-020-01041-y","article-title":"High-accuracy long-read amplicon sequences using unique molecular identifiers with Nanopore or PacBio sequencing","volume":"18","author":"Karst","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2024.101208_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo7676","article-title":"Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing","volume":"8","author":"Park","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2024.101208_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101208_bib25","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V90.7.2680","article-title":"Wiskott-Aldrich syndrome\/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype","volume":"90","author":"Zhu","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2024.101208_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<54::AID-HUMU7>3.0.CO;2-E","article-title":"Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes","volume":"14","author":"Lemahieu","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2024.101208_bib27","doi-asserted-by":"crossref","first-page":"e3444","DOI":"10.1371\/journal.pone.0003444","article-title":"Evolution of highly polymorphic T\u00a0cell populations in siblings with the Wiskott-Aldrich Syndrome","volume":"3","author":"Lutskiy","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101208_bib28","article-title":"Deep Profiling Reveals Substantial Heterogeneity of Integration Outcomes in CRISPR Knock-In Experiments","author":"Canaj","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2024.101208_bib29","article-title":"In\u00a0Vivo Expansion of Gene-Targeted Hepatocytes through Transient Inhibition of an Essential Gene","author":"Giorgi","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2024.101208_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of Adeno-Associated Virus (AAV) and Recombinant AAV Vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.omtm.2024.101208_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cobme.2023.100478","article-title":"Detection and quantification of unintended large on-target gene modifications due to CRISPR\/Cas9 editing","volume":"28","author":"Park","year":"2023","journal-title":"Current Opinion in Biomedical Engineering"},{"key":"10.1016\/j.omtm.2024.101208_bib32","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101208_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12026-008-8091-4","article-title":"Revertant somatic mosaicism in the Wiskott-Aldrich syndrome","volume":"44","author":"Davis","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omtm.2024.101208_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2009.12.011","article-title":"Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants","volume":"135","author":"Davis","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.omtm.2024.101208_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-0716-1979-7_19","article-title":"Identification and Validation of CRISPR\/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells","volume":"2429","author":"Park","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2024.101208_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101208_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep30564","article-title":"Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours","volume":"6","author":"Filtjens","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101208_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1189\/jlb.0812378","article-title":"Abundant stage-dependent Ly49E expression by liver NK cells is not essential for their differentiation and function","volume":"93","author":"Filtjens","year":"2013","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.omtm.2024.101208_bib39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.celrep.2017.04.068","article-title":"A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties","volume":"19","author":"Van Acker","year":"2017","journal-title":"Cell Rep."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012400024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012400024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T17:14:21Z","timestamp":1722100461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012400024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S232905012400024X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101208","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101208"}}